Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis

Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis

US Patent 10172866 · Granted Jan 8, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CDK9 inhibitors2025
Quinoline and quinazoline compounds and methods of use thereof2022
Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of no2021
Substituted pyrimidines for inhibiting embryonic leucine zipper kinase activity2021
Arf6 inhibitors and methods of synthesis and use thereof2020
JAK1 and ALK2 inhibitors and methods for their use2020
Methods and compositions for inhibition of bromodomain-containing proteins2020
Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of 2020
Substituted 2, 3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear rec2020
Substituted 2, 3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear rec2020
Methods and compositions for inhibition of bromodomain-containing proteins2019
JAK2 and ALK2 inhibitors and methods for their use2019